Search Results for "amlodipine"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for amlodipine. Results 1 to 4 of 4 total matches.
Drugs for Hypertension
The Medical Letter on Drugs and Therapeutics • May 27, 2024 (Issue 1703)
Cost2
Frequent or Severe
Adverse Effects3
Dihydropyridines
Amlodipine besylate4 – generic
Norvasc ...
American College of Cardiology/American Heart
Association (ACC/AHA) guidelines for treatment of
hypertension were last published in 2018. Treatment
of hypertensive urgencies and emergencies is not
discussed here.
Med Lett Drugs Ther. 2024 May 27;66(1703):81-8 doi:10.58347/tml.2024.1703a | Show Introduction Hide Introduction
Aprocitentan (Tryvio) for Hypertension
The Medical Letter on Drugs and Therapeutics • Jun 10, 2024 (Issue 1704)
antihypertensive drugs. All patients were switched to
a fixed-dose combination of amlodipine 5 or 10 mg
(highest ...
The FDA has approved the dual endothelin receptor
antagonist aprocitentan (Tryvio – Idorsia) for
use in combination with other antihypertensive
drugs to treat hypertension in adults whose blood
pressure is not adequately controlled on other drugs.
Three other dual endothelin receptor antagonists,
ambrisentan (Volibris, and generics), bosentan
(Tracleer, and generics), and macitentan (Opsumit),
are available in the US for treatment of pulmonary
arterial hypertension.
Med Lett Drugs Ther. 2024 Jun 10;66(1704):92-3 doi:10.58347/tml.2024.1704b | Show Introduction Hide Introduction
Comparison Table: Some Lipid-Lowering Drugs (online only)
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022 (Issue 1659)
, or verapamil and 20 mg if taken with amiodarone, amlodipine, or ranolazine.
7. Inhibitors and inducers of CYP ...
View the Comparison Table: Some Lipid-Lowering Drugs
Lipid-Lowering Drugs
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022 (Issue 1659)
with amiodarone, amlodipine, or ranolazine.
14. Not recommended for use in patients with moderate to severe ...
Cholesterol management guidelines from the
American College of Cardiology/American Heart
Association Task Force were last published in 2019.